R
Rivet
Building tools that give providers and patients transparent pricing and seamless transactions
About Rivet
Rivet Health operates in the healthcare payment solutions market, serving medical practices and healthcare providers. The company specializes in managing payer contracts and fee schedules, ensuring that healthcare providers receive accurate payments for their services. Rivet Health's core product is a comprehensive dashboard that organizes and simplifies complex payer contracts and fee schedules, making it easier for healthcare providers to understand and manage their financial transactions. The company leverages advanced machine learning algorithms to provide hyper-accurate patient cost estimates, which are continuously refined based on practice data, billing rules, and contract details. This allows healthcare providers to offer transparent pricing to their patients and improve their overall financial operations. Rivet Health integrates seamlessly with any existing system, ensuring that practices can adopt their solutions without disrupting their current workflows. The business model is primarily subscription-based, with healthcare providers paying for access to Rivet Health's platform and services. Revenue is generated through these subscriptions as well as potential additional fees for premium features or services. The company aims to streamline administrative tasks, reduce underpayment issues, and enhance patient payment experiences, ultimately leading to better financial health for medical practices.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2018
- Headquarters
- Salt Lake City, United States
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 59.4/100
- Industry
- Health, Fintech
- Sub-industry
- Health Platform, Payments
- Sector
- Health Tech & Medtech, Hard Tech
- Business model
- SaaS
- Client focus
- b2b, b2c
Latest news
Press, funding announcements and product moves mentioning Rivet.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2026 | $0 | — | Zelis | ↗ |
| SERIES B✓Equity / VC | Jun 2022 | $21M | $82M | Lux Capital · Ankona Capital · Menlo Ventures · Pelion Venture Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Rivet is 46K monthly website visits, down 38.7% over the last three months. Rivet's team declined 57.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A4 investors entered at this stage
Menlo Ventures
Pelion Venture Partners
Catalyst Investors
Ankona Capital
Other known investors3 additional known investors
Zelis
Brad Perry
Davis Bell
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rivet on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rivet’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.